Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Patricia Hernández-Carabias"'
Autor:
Elena Vuelta, Ignacio García-Tuñón, Patricia Hernández-Carabias, Lucía Méndez, Manuel Sánchez-Martín
Publikováno v:
Biology, Vol 10, Iss 2, p 118 (2021)
The constitutively active tyrosine-kinase BCR/ABL1 oncogene plays a key role in human chronic myeloid leukemia development and disease maintenance, and determines most of the features of this leukemia. For this reason, tyrosine-kinase inhibitors are
Externí odkaz:
https://doaj.org/article/5978d12781ee46f9be1186ac44cddf38
Autor:
Xavier Sanchez Saez, Henar Albertos‐Arranz, María José Ruiz Pastor, Oksana Kutsyr, Natalia Martínez‐Gil, Laura Fernández‐Sánchez, Carla Sánchez Castillo, Carmen Aguilera, Lucía Méndez, Patricia Hernández‐Carabias, Victoria Maneu, Pedro Lax, Nicolas Cuenca
Publikováno v:
Acta Ophthalmologica. 100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf119019c24b8ac4fbc744be0a1a4d53
https://doi.org/10.1111/j.1755-3768.2022.011
https://doi.org/10.1111/j.1755-3768.2022.011
Autor:
Manuel Sánchez-Martín, Elena Vuelta, Lucía Méndez, Ignacio García-Tuñón, Patricia Hernández-Carabias
Publikováno v:
Biology
Digital.CSIC. Repositorio Institucional del CSIC
instname
Biology, Vol 10, Iss 118, p 118 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Biology, Vol 10, Iss 118, p 118 (2021)
© 2021 by the authors.
The constitutively active tyrosine-kinase BCR/ABL1 oncogene plays a key role in human chronic myeloid leukemia development and disease maintenance, and determines most of the features of this leukemia. For this reason, ty
The constitutively active tyrosine-kinase BCR/ABL1 oncogene plays a key role in human chronic myeloid leukemia development and disease maintenance, and determines most of the features of this leukemia. For this reason, ty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d7a3e341f8551b053296d908f85132c
https://pubmed.ncbi.nlm.nih.gov/33557401
https://pubmed.ncbi.nlm.nih.gov/33557401
Autor:
Fermín Sánchez-Guijo, Patricia Hernández-Carabias, Lucía Méndez, Elena Vuelta, Julián Sevilla, Elena Sebastian, Jesús María Hernández-Rivas, Raquel Saldaña, José Luis Ordóñez, Verónica Alonso-Pérez, Sandra Muntión, Manuel Sánchez-Martín, Ignacio García-Tuñón
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Chronic myeloid leukemia (CML) is a hematopoietic malignancy produced by a unique oncogenic event involving the constitutively active tyrosine-kinase (TK) BCR/ABL1. TK inhibitors (TKI) changed its prognosis and natural history. Unfortunately, ABL1 re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a4e2bf9ad7c00aa0ff050b3216f3b49
http://hdl.handle.net/10261/261299
http://hdl.handle.net/10261/261299
Autor:
José Luis Ordóñez, Verónica Alonso-Pérez, Jesús María Hernadez-Rivas, Lucía Méndez, Elena Vuelta, Patricia Hernández-Carabias, Julián Sevilla, Raquel Saldaña, Fermín Sánchez-Guijo, Sandra Muntión, Elena Sebastian, Ignacio García-Tuñón, Manuel Sánchez-Martín
Chronic myeloid leukemia (CML) is a hematopoietic stem cell disease produced by a unique oncogenic event involving the constitutively active tyrosine kinase (TK) BCR/ABL1. TK activity explains most features of CML, such as tumor development and maint
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8287da88e4ff74d3771f3974b07d342b
https://doi.org/10.1101/2020.08.05.237610
https://doi.org/10.1101/2020.08.05.237610